Oxycodone Base
Generic Name: oxycodone base
Dosage form: POWDER. Active ingredients: OXYCODONE (1 kg/1). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: POWDER. Active ingredients: OXYCODONE (1 kg/1). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as powder.
Related Medications
Pegcetacoplan
pegcetacoplan
Complement Inhibitor [EPC]
11 DESCRIPTION SYFOVRE contains pegcetacoplan, a complement inhibitor. Pegcetacoplan is a symmetrical molecule composed of two identical pentadecapeptides covalently bound to the ends of a linear 40 kiloDalton (kDa) polyethylene glycol (PEG) molecule. The peptide portions of pegcetacoplan contain 1-methyl-L-tryptophan (Trp(Me)) in position 4 and amino (ethoxyethoxy) acetic acid (AEEA) in position 14. The molecular weight of pegcetacoplan is approximately 43.5 kDa.
Avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 2.7%, Oxybenzone 6%
avobenzone 3%, homosalate 10%, octisalate 5%, octocrylene 2.7%, oxybenzone 6%
Purpose Sunscreen
Quinapril And Hydrochlorothiazide
quinapril and hydrochlorothiazide
Thiazide Diuretic [EPC]
DESCRIPTION Quinapril and Hydrochlorothiazide Tablets, USP are a fixed-combination tablet that combines an angiotensin-converting enzyme (ACE) inhibitor, quinapril hydrochloride, and a thiazide diuretic, hydrochlorothiazide. Quinapril hydrochloride is chemically described as [3S-[2[R*(R*)], 3R*]]-2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3- isoquinolinecarboxylic acid, monohydrochloride. Its empirical formula is C 25 H 30 N 2 O 5 .
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.